Covid-19 Vaccinations at Super Speciality Hospital as India Plans to Innoculate 300 Million by July

A health worker records details in the Covid-19 vaccination room at the Super Speciality Hospital Hospital in Srinagar, India, on Friday, Jan. 29, 2021. India's domestic vaccine program administers one of two shots: the AstraZeneca Plc vaccine, manufactured by the Serum Institute of India Ltd., or the Covaxin shot developed by Bharat Biotech International Ltd., a private company based in Hyderabad. Photographer: Sumit Dayal/Bloomberg via Getty Images
A health worker records details in the Covid-19 vaccination room at the Super Speciality Hospital Hospital in Srinagar, India, on Friday, Jan. 29, 2021. India's domestic vaccine program administers one of two shots: the AstraZeneca Plc vaccine, manufactured by the Serum Institute of India Ltd., or the Covaxin shot developed by Bharat Biotech International Ltd., a private company based in Hyderabad. Photographer: Sumit Dayal/Bloomberg via Getty Images
Covid-19 Vaccinations at Super Speciality Hospital as India Plans to Innoculate 300 Million by July
PURCHASE A LICENCE
How can I use this image?
£375.00
GBP

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
1230850530
Collection:
Bloomberg
Date created:
29 January, 2021
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
INDIA VACCINE
Max file size:
4000 x 2667 px (33.87 x 22.58 cm) - 300 dpi - 4 MB